Ala. Admin. Code r. 540-X-17-.04

Current through Register Vol. 43, No. 1, October 31, 2024

Section 540-X-17-.04 - Initial Requirements

(1) Before initiating treatment for weight reduction or obesity utilizing any Schedule III, IV or V controlled substance, a physician should comply with the following:

(a) An initial evaluation of the patient should be conducted by and recorded by the prescribing physician prior to the prescribing, ordering, dispensing or administering of any drug. Such evaluation should include an appropriate physical and complete history; appropriate tests related to medical treatment for weight reduction; and appropriate medical referrals as indicated by the physical, history, and testing; all in accordance with general medical standards of care. Relative contraindications to the use of anorectic drugs should be addressed prior to prescribing or dispensing these medications.

(b) The patient should have a Body Mass Index (BMI) of 30 or above, or a BMI of greater than 25 with at least one comorbitity factor, or a measurable body fat content equal to or greater than 25% of total body weight for male patients or 30% of body weight for female patients, or an abdominal girth of at least 40 inches for male patients or an abdominal girth of at least 35 inches for female patients. BMI is calculated by use of the formula BMI=kg/m².

(c) The prescribing physician should assess and document the patient's freedom from signs of drug or alcohol abuse and the presence or absence of contraindications and adverse side effects.

Ala. Admin. Code r. 540-X-17-.04

New Rule: Filed December 16, 2011; effective January 20, 2012.

Author: Alabama Board of Medical Examiners

Statutory Authority:Code of Ala. 1975, § 34-24-53.